Fixed Drug Eruption due to Chlorpheniramine: Case Report

Affiliations

¹ Allergy Department, Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain.
² Allergy Department, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain.
³ Dermatology Department, Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain.

Case Reports

Vanesa García Paz et al. Contact Dermatitis. 2025 Apr.

. 2025 Apr;92(4):316-317.

doi: 10.1111/cod.14738. Epub 2024 Dec 30.

¹ Allergy Department, Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain.
² Allergy Department, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain.
³ Dermatology Department, Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain.

No abstract available

Keywords: CAS no; Chlorphenamine; Dexchlorpheniramine; allergy; case report; fixed drug eruption.

References

1. B. J. De Paramo, S. Q. Gancedo, M. Cuevas, I. P. Camo, J. A. Martin, and E. L. Cosmes, “Paracetamol (Acetaminophen) Hypersensitivity,” Annals of Allergy, Asthma & Immunology 85, no. 6 (2000): 508–511, https://doi.org/10.1016/S1081‐1206(10)62580‐X.
1. A. C. de Groot, Patch Testing, Test Concentrations and Vehicles for 4350 Chemicals, 3rd ed. (Wapserveen, The Netherlands: Elsevier Science, 2008).
1. F. E. R. Simons and K. J. Simons, “Histamine and H1‐Antihistamines: Celebrating a Century of Progress,” Journal of Allergy and Clinical Immunology 128, no. 6 (2011): 1139–1150.e4, https://doi.org/10.1016/j.jaci.2011.09.005.
1. A. S. Pereira, D. Flor, and M. Gonçalo, “A Case of Fixed Drug Eruption From Cetirizine With Cross‐Reaction to Levocetirizine and Hydroxyzine,” Contact Dermatitis 88, no. 4 (2023): 318–319, https://doi.org/10.1111/cod.14270.
1. J. Calvão, J. C. Cardoso, and M. Gonçalo, “Fixed Drug Eruption to Rupatadine With Positive Patch Tests on Non‐Lesional Skin,” Contact Dermatitis 83, no. 3 (2020): 239–241, https://doi.org/10.1111/cod.13576.